Biotherapy Treatment on Features of Microcrystalline Polyarthritis (FUMBLE)

Regional University Hospital Center (CHRU)

Status: Completed

Conditions: Crystal-Induced Arthritis

Study type: Observational

Funder types: Other

Identifiers

NCT04005625

29BRC19.0056

Details and patient eligibility

About

The study will involve adult patient who had received any biologic agent for microcrystalline disease in western France (Tours, Le Mans, Orléans, Angers, Rennes, Poitiers et Brest) between 01/01/2010 and 31/12/2018.

Investigators will answer retrospectively a questionnaire that covers patient and disease data, biologic agent use, efficacy and adverse events.

Full description

This is a retrospective multicentric study of all patients treated by biologic for microcrystalline disease in France in western France (Tours, Le Mans, Nantes, La Roche sur Yon, Orléans, Angers, Rennes, Poitiers et Brest) between 01/01/2010 and 31/12/2018.

The investigators will collect all clinical (diagnosis of gout CCPD or hydroxyapatitis, tender and swollen joint count), biological (blood results: ESR, CRP, uric acid, synovial analysis), radiological data (X-rays performed and their description) .

Enrollment: 46 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Crystal- induced arthritis
• Treatment by biologic
• In western France

Exclusion criteria

• None